These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 791566)

  • 1. [Current status of hepatic and biliary drug therapy. Part I].
    Donatelli L; Marmo E
    Clin Ter; 1976 Mar; 76(5):395-409. PubMed ID: 791566
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of xylite on hepatic and pancreatic function in biliary pathology].
    Rafes IuI; Sheleketina II; Voroteliak VS; Kulikova ZS; Mel'nichenko LIa
    Vrach Delo; 1972 Feb; 2():10-4. PubMed ID: 5084716
    [No Abstract]   [Full Text] [Related]  

  • 3. [The characteristics of the use of ursodeoxycholic acid in chronic diseases of the hepatobiliary system].
    Dehtiar'ova II; Chernenko VV; Anokhina HA; Opanasiuk ND; Pavlik-Novol's'kyĭ T; Haĭsenko AV
    Lik Sprava; 1995; (9-12):47-8. PubMed ID: 8983789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chologonic and choleretic action of the Soviet preparation xylite].
    Grancharov VP
    Vopr Pitan; 1971; 30(6):18-20. PubMed ID: 5131655
    [No Abstract]   [Full Text] [Related]  

  • 5. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV; Lebedeva OI
    Voen Med Zh; 2001 Feb; 322(2):49-53. PubMed ID: 11338822
    [No Abstract]   [Full Text] [Related]  

  • 6. [Amphocholeretic effect of Fumaria officinalis].
    Fiegel G
    Z Allgemeinmed; 1971 Dec; 47(34):1819-20. PubMed ID: 5134143
    [No Abstract]   [Full Text] [Related]  

  • 7. [Choleretic effect of Bulgarian rose oil].
    Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF
    Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic approaches for hepatobiliary disorders with ursodeoxycholic acid and bile-acid derivatives.
    Serfaty L; Poupon R
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S1. PubMed ID: 23141887
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hepatobiliary lesions in Crohn's disease and conservative methods of treatment].
    Grigor'eva GA; Meshalkina NIu
    Eksp Klin Gastroenterol; 2013; (6):3-6. PubMed ID: 24772851
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of an hepatobiliary analeptic agent].
    Chapuy H; Jeune M; Sambin P; Girard M
    J Med Lyon; 1971 Jun; 52(211):1025-34. PubMed ID: 5138331
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholagogic agents].
    Pasichnyk IKh
    Farm Zh; 1978; (2):39-43. PubMed ID: 658339
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled double-blind clinical study of cinnametic acid, a new choleretic agent in hepatobiliary diseases].
    Marchettini G; Maggi P; Benvenuti C
    Clin Ter; 1978 Sep; 86(5):485-94. PubMed ID: 367683
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of pecvocrine on the biligenic function of the liver in acute experimental hepatitis].
    Pasechnik IKh
    Farmakol Toksikol; 1973; 36(1):103-4. PubMed ID: 4685141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical classification of current choleretic preparations].
    Skakun NP
    Vrach Delo; 1965 Aug; 8():26-9. PubMed ID: 5870987
    [No Abstract]   [Full Text] [Related]  

  • 15. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 16. [New aspects of pharmacological effects of ursodeoxycholic acid].
    Radchenko VG; Seliverstov PV; Sitkin SI
    Eksp Klin Gastroenterol; 2014; (8):4-10. PubMed ID: 25911905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of altan on the functional activity of the liver mitochondria and microsomes from rats with toxic hepatitis].
    Gordienko AD; Iakovleva LV
    Eksp Klin Farmakol; 1999; 62(4):59-61. PubMed ID: 10513340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with the amphocholereticum Oddibil].
    Zawodsky L
    Wien Med Wochenschr; 1974 Nov; 124(46):677-80. PubMed ID: 4617977
    [No Abstract]   [Full Text] [Related]  

  • 19. [Correction of disruption of oxidative processes by dimethyl sulfoxide and alpha-tocopherol in acute chemical injury to the liver].
    Gonskiĭ IaI; Korda MM; Klishch IN; Fira LS
    Vopr Med Khim; 1996; 42(1):30-4. PubMed ID: 8999655
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective potentiation of carbon tetrachloride hepatotoxicity by ethanol.
    Wei E; Wong LC; Hine CH
    Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):5-11. PubMed ID: 5130154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.